HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Persistence of Vascular Calcification after Reversal of Uremia.

Abstract
The extent to which vascular calcification is reversible and the possible mechanisms are unclear. To address this, calcified aortas from uremic mice were transplanted orthotopically into normal mice, and the calcium content, histology, and minerals of the allografts were compared with the nontransplanted donor aorta. Calcium content decreased immediately after transplantation but remained constant thereafter, with 68% ± 12% remaining after 34 weeks. X-ray diffraction showed the presence of apatite in both donor aortas and allografts. Osteoclasts were absent in the allografts and there was no expression of the macrophage marker CD11b, the osteoclast marker tartrate-resistant acid phosphatase, or carbonic anhydrase II. The initial loss of calcium was less in heavily calcified aortas and was associated with an increase in the Ca/P ratio from 1.49 to 1.63, consistent with a loss of nonapatitic calcium. The results indicate that vascular calcification persists after reversal of uremia, because of a lack of active resorption of apatite. This failure to resorb established calcifications may contribute to the severity of vascular calcification and suggests that therapy should be aimed at prevention.
AuthorsKoba A Lomashvili, Kelly E Manning, M Neale Weitzmann, Valentin Nelea, Marc D McKee, W Charles O'Neill
JournalThe American journal of pathology (Am J Pathol) Vol. 187 Issue 2 Pg. 332-338 (Feb 2017) ISSN: 1525-2191 [Electronic] United States
PMID27939134 (Publication Type: Journal Article)
CopyrightCopyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Topics
  • Allografts
  • Animals
  • Aorta (pathology, transplantation)
  • Disease Models, Animal
  • Mice
  • Mice, Inbred C57BL
  • Uremia (complications)
  • Vascular Calcification (etiology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: